Feed / MEDP

Medpace Holdings, Inc.

MEDP

Healthcare · 622.85 +1.2% today

Isolated · not yet confirmedMarket checked 29 Sept, 10:05 GMT-4

Market read

No connected market move is active around Medpace Holdings, Inc..

The latest filing evidence is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

What changed
  • Revenue increased 26.5% versus the comparable filing period.
  • Net margin fell 3.0 percentage points.
Company+1.2% todayVolume comparison unavailable
Market groupNo active group readNo durable group available
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • MEDP's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if MEDP's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Diagnostics & Research

The latest filing evidence is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 26.5% versus the comparable filing period.
  • Operating cash flow covered net income at 1.23x, improving versus the comparable period.
Evidence that challenges
  • Net margin fell 3.0 percentage points.
What would clarify the read
  • MEDP's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 29, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations339
Usable filing statements63
Verified relationships4
Evidence supporting the case
  • Latest annual revenue changed +20.0% year over year.
  • Operating cash flow covered net income at 1.58x in the latest annual period.
Evidence challenging the case
  • Net margin changed -1.3 percentage points in the latest annual period.
Questions before a position
  • EV/sales is 254% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 28, 2026

615.73
6m+36.5%12m+26.2%24m—
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$1.1B+23.4%$4.81-0.0%
2022-12-31$1.5B+27.8%$7.28-10.7%
2023-12-31$1.9B+29.2%$8.88-5.4%
2024-12-31$2.1B+11.8%$12.63+0.5%
2025-12-31$2.5B+20.0%$15.28-7.8%

What management says matters

Persistent and emerging business drivers

Supply chain and availabilitymixed · 1 filings
“Costs of sales and marketing activities not subject to recovery pursuant to customer contracts, such as feasibility assessments and negotiation of contracts, are expensed as incurred and recorded as a component of Selling, general and administrative in the ac…”
10-K · Feb 10, 2026 ↗

Valuation discipline

Descriptive valuation snapshot

Price/sales 7.2× · EV/sales 7.0×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

622.85+1.2% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 30 Sept, 11:25 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for MEDP. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

Fundamentals strengthened in the latest filing

10-Q filed 2026-04-23 against the comparable filing from 2025-04-22.

constructive
OperationsconstructiveEvidence score +2
liquidityconstructiveEvidence score +1
valuationmixed

What improved

  • Revenue increased 26.5% versus the comparable filing period.
  • Operating cash flow covered net income at 1.23x, improving versus the comparable period.

What weakened

  • Net margin fell 3.0 percentage points.

Filing receipts

“Selling, General and Administrative Selling, general and administrative expenses are primarily driven by compensation and related employee benefits, as well as rent, utilities, supplies, software licenses, professional fees (e.g., legal and accounting expenses), bad debt expense, travel, marketing and other operating expenses.”

“Changes in operating assets and liabilities used $18.9 million in operating cash flows and was primarily driven by decreased accrued expenses of $23.2 million and increased prepaid expenses and other current assets of $17.6 million, partially offset by changes in other assets and liabilities, net of $11.6 million, increased accounts payable of $10.7 million and increased advanced billings of $8.1 million.”

“Changes in operating assets and liabilities used $8.7 million in operating cash flows and was primarily driven by changes in other assets and liabilities, net of $10.2 million and decreased lease liabilities of $5.3 million, partially offset by decreased accounts receivable and unbilled, net of $7.8 million and increased advanced billings of $2.0 million.”

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind MEDP

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

FTREFortrea Holdings Inc.competitorFeb 10, 2026 ▾

“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”

ICLRICON Public Limited CompanycompetitorFeb 10, 2026 ▾

“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”

IQVIQVIA Holdings Inc.competitorFeb 10, 2026 ▾

“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MEDP is currently a Follower in the organic co-movement group Unknown Theme. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for MEDP; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.